Understanding Ivermectin  for COVID-19 Treatment

The Academy of Science of South Africa (ASSAf) cordially invites you to a webinar on Understanding Ivermectin  for COVID-19 Treatment (Risks, Benefits and the Law).


Prof Mosa Moshabela, Chair: ASSAf Health Standing Committee, Acting Deputy Vice-Chancellor Research and Innovation at the University of KwaZulu-Natal (UKZN)


  • Dr Tamara Kredo, Senior Specialist Scientist at the South African Cochrane Centre,
  • South African Medical Research Council
  • Prof Vinny Naidoo, Dean of the Faculty of Veterinary Science, University of Pretoria
  • Prof Donrich Thaldar, School of Law, University of KwaZulu-Natal

Date:    12 April 2021

Time:  10:00 to 12:00

Platform:  Zoom

RSVP:    Click here to register

COVID-19 is a public health emergency of international concern and there is no specific treatment for it. This fact, together with the excellent safety profile of Ivermectin combine to warrant research on its potential use. In an attempt to understand Ivermectin and its potential use in COVID-19 the ASSAf webinar aims to unpack common questions on this topic and to highlight the involvement of researchers and regulatory bodies in finding answers to some of them.